Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1998-02-20
1999-11-02
Kunz, Gary L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 245, 536 243, C07H 2100, C07H 2104, A61K 3170
Patent
active
059773324
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 are each independently of the other hydrogen or a protecting group, or
REFERENCES:
patent: 5750673 (1998-05-01), Martin
W. Muller, Institut furPhysiologische Chemie, Abteilung "Angewandte Molekularbiologie", Universitat, Duesbergweg, 6500 Mainz, W. Germany, pp. 274-279 (1979).
S. T. Crooke et al., Antisense Research and Applications Eds., CRC Press, Boca Raton, pp. 273-288, (1993).
G. Bott et al., J. Am. Chem. Soc., vol. 102, pp. 5618-5626 (1980).
A. Rossi, Institute Nazionale Tumori, pp. 409-436 (1979).
R.W. Sidwell, Research Professor of Biology and of Animal, Dairy and Veterinary Sciences, Utah State Univ., pp. 337-362 (1979).
F.M. Schabel, Jr., Southern Research Institute, Birmingham, Ala., pp. 363-394 (1979).
J.C. Martin, Nucleotide Analogues as Antiviral Agents, ACS Symposium Series 401, Table of Contents (1988).
W. Prusoff et al., Yale Univ. Sch. of Med. Dept. of Pharm. pp. 281-318 (1979).
T. Merigan et al., Stanford Univ. Div. of Infectious Diseases, pp. 395-407 (1979).
R. Walker et al., Nucleoside Analogues Chemistry, Biology and Medical Applications, Table of Contents (1979).
J.A. Martin et al., American Chemical Society, Design of Inhibitors of Herpes Simplex Virus Thymidine Kinase, Chapter 7, (1989).
V. E. Marquez, American Chemical Society, Design, Synthesis and Antiviral Activity of Nucleoside and Nucleotide Analogues, Chapter 10 (1989).
Frochler, BC et al. Tetrahedron Letters 34 (1993), pp. 1003-1006.
Lesnik, E.A. et al., Biochemistry 32 (1993), pp. 7832-7838.
Chemical Abstracts 122 (1995), abstract No. 56416V.
Beaucage, S.L., Iyer, R., Tetrahedron 48:2223-2311 (1992).
Matteucci, M.D., Bischofberger, N., Annual Reports in Medicinal Chemistry, 26: 287-296 (1991).
Helene, C., Toulme, J.J., Biochimica et Biophysica Acta 1049:99-125 (1990).
Marquez, V.E., Lim, M.I., Medicinal Research Reviews 6:1-40 (1986).
Uhlmann, E., Peyman A., Chemical Reviews, 90:543-584 (1990).
Sonveaux E., Bioorganic Chemistry 14:274-325 (1986).
Marky, L.A., Breslauer, K.J., Biopolymers 26:1601-1620 (1987).
Cook, P.D., Anti-Cancer Drug Design 6:585-607 (1991).
Uwe English et al., Angewandte Chemie Int. Ed. 30; pp. 613-722, (1991).
Ferraro Gregory D.
Kunz Gary L.
Novartis Corporation
LandOfFree
Oligonucleotides having 2'-ether groups does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides having 2'-ether groups, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides having 2'-ether groups will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2137056